I am partnered with a global pharmaceutical company who builds the understanding of diseases and drugs by developing and applying innovative translational strategies (including biomarkers, clinical pharmacology, pharmacometrics and digital approaches) across the entire clinical development pipeline.
My client drive projects fast and stringently to informed decisions on first-in-man, proof of pharmacological principle (PoPP), proof of clinical principle (PoCP) and proof of clinical concept (PoCC) up to submission.
Are you looking for a new senior challenge in Cardio-Metabolic? If so, read on further...
Define high quality and innovative clinical biomarker strategies to enable your projects to achieve the important early clinical milestone of Proof of Clinical Principle
Accountable for the successful implementation of the biomarker strategy in clinical studies, in close collaboration with Biomarker Technology Platforms and other internal and external partners
Design and execute exploratory translational medicine studies to ensure a better characterization of patient populations or to qualify biomarkers in close collaboration with internal scientists and leading external experts
Participation in academic and industrial consortia.
Leading role in the implementation of Precision Medicine concepts in assigned projects.
Provide input into the preclinical identification of candidate biomarkers and the assessment of their usefulness during clinical development
Opportunity to represent Translational Medicine & Clinical Pharmacology in strategic project teams including agency meetings
In the Principal role, you act as the primary internal reference contact concerning translational and biomarker approaches in Cardio-metabolic indications.
Requirements for a Senior Position
Medical degree or PhD in a relevant field
Appropriate scientific and individual qualification, including postdoctoral experience of several years and working experience in the development and implementation of biomarker concepts in a pharmaceutical or diagnostic company
Expert-level disease-area knowledge with strong scientific knowledge of the pathophysiology and the main therapeutic modalities currently approved or in clinical development
Knowledge and experience of the drug development process and a clear understanding of the applicable regulatory requirements
Personal track record in the implementation of biomarkers in drug development
The ability to present a well-reasoned business case and to influence others to support cross-functional implementation of new initiatives and projects
Vincenzo Dessena MSc. BSc.
vdessena (at) barringtonjames.com